Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
Mahlangu, Johnny, Oldenburg, Johannes, Paz-Priel, Ido, Negrier, Claude, Niggli, Markus, Mancuso, M. Elisa, Schmitt, Christophe, Jiménez-Yuste, Victor, Kempton, Christine, Dhalluin, Christophe, Callaghan, Michael U, Bujan, Willem, Shima, Midori, Adamkewicz, Joanne I, Asikanius, Elina, Levy, Gallia G, Kruse-Jarres, Rebecca
Published in The New England journal of medicine (30.08.2018)
Published in The New England journal of medicine (30.08.2018)
Get full text
Journal Article
A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A
Yoneyama, Koichiro, Schmitt, Christophe, Kotani, Naoki, Levy, Gallia G., Kasai, Ryu, Iida, Satofumi, Shima, Midori, Kawanishi, Takehiko
Published in Clinical pharmacokinetics (01.09.2018)
Published in Clinical pharmacokinetics (01.09.2018)
Get full text
Journal Article
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Ginsburg, David, Levy, Gallia G, Nichols, William C, Lian, Eric C, Foroud, Tatiana, McClintick, Jeanette N, McGee, Beth M, Yang, Angela Y, Siemieniak, David R, Stark, Kenneth R, Gruppo, Ralph, Sarode, Ravindra, Shurin, Susan B, Chandrasekaran, Visalam, Stabler, Sally P, Sabio, Hernan, Bouhassira, Eric E, Upshaw, Jefferson D, Tsai, Han-Mou
Published in Nature (London) (04.10.2001)
Published in Nature (London) (04.10.2001)
Get full text
Journal Article
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3
Callaghan, Michael U., Asikanius, Elina, Lehle, Michaela, Oldenburg, Johannes, Mahlangu, Johnny, Uguen, Marianne, Chebon, Sammy, Kruse‐Jarres, Rebecca, Jiménez‐Yuste, Víctor, Shima, Midori, Trask, Peter, Kempton, Christine L., Kessler, Craig M., Levy, Gallia G., Peyvandi, Flora
Published in Research and practice in thrombosis and haemostasis (01.08.2022)
Published in Research and practice in thrombosis and haemostasis (01.08.2022)
Get full text
Journal Article
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Oldenburg, Johannes, Mahlangu, Johnny N, Kim, Benjamin, Schmitt, Christophe, Callaghan, Michael U, Young, Guy, Santagostino, Elena, Kruse-Jarres, Rebecca, Negrier, Claude, Kessler, Craig, Valente, Nancy, Asikanius, Elina, Levy, Gallia G, Windyga, Jerzy, Shima, Midori
Published in The New England journal of medicine (31.08.2017)
Published in The New England journal of medicine (31.08.2017)
Get full text
Journal Article
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Young, Guy, Liesner, Ri, Chang, Tiffany, Sidonio, Robert, Oldenburg, Johannes, Jiménez-Yuste, Victor, Mahlangu, Johnny, Kruse-Jarres, Rebecca, Wang, Michael, Uguen, Marianne, Doral, Michelle Y., Wright, Lilyan Y., Schmitt, Christophe, Levy, Gallia G., Shima, Midori, Mancuso, Maria Elisa
Published in Blood (12.12.2019)
Published in Blood (12.12.2019)
Get full text
Journal Article
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies
Callaghan, Michael U., Negrier, Claude, Paz-Priel, Ido, Chang, Tiffany, Chebon, Sammy, Lehle, Michaela, Mahlangu, Johnny, Young, Guy, Kruse-Jarres, Rebecca, Mancuso, Maria Elisa, Niggli, Markus, Howard, Monet, Bienz, Nives Selak, Shima, Midori, Jiménez-Yuste, Victor, Schmitt, Christophe, Asikanius, Elina, Levy, Gallia G., Pipe, Steven W., Oldenburg, Johannes
Published in Blood (22.04.2021)
Published in Blood (22.04.2021)
Get full text
Journal Article
Sialyltransferase ST3Gal-IV Operates as a Dominant Modifier of Hemostasis by Concealing Asialoglycoprotein Receptor Ligands
Ellies, Lesley G., Ditto, David, Levy, Gallia G., Wahrenbrock, Mark, Ginsburg, David, Varki, Ajit, Le, Dzung T., Marth, Jamey D.
Published in Proceedings of the National Academy of Sciences - PNAS (23.07.2002)
Published in Proceedings of the National Academy of Sciences - PNAS (23.07.2002)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Schmitt, Christophe, Adamkewicz, Joanne I., Xu, Jin, Petry, Claire, Catalani, Olivier, Young, Guy, Negrier, Claude, Callaghan, Michael U., Levy, Gallia G.
Published in Thrombosis and haemostasis (01.03.2021)
Published in Thrombosis and haemostasis (01.03.2021)
Get full text
Journal Article
Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program
Levy, Gallia G., Asikanius, Elina, Kuebler, Peter, Benchikh El Fegoun, Soraya, Esbjerg, Sille, Seremetis, Stephanie
Published in Journal of thrombosis and haemostasis (01.09.2019)
Published in Journal of thrombosis and haemostasis (01.09.2019)
Get full text
Journal Article
A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A
Yoneyama, Koichiro, Schmitt, Christophe, Chang, Tiffany, Dhalluin, Christophe, Nagami, Sayaka, Petry, Claire, Levy, Gallia G.
Published in Journal of clinical pharmacology (01.02.2022)
Published in Journal of clinical pharmacology (01.02.2022)
Get full text
Journal Article
Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study
Kiialainen, Anna, Niggli, Markus, Kempton, Christine L., Castaman, Giancarlo, Chang, Tiffany, Paz‐Priel, Ido, Adamkewicz, Joanne I., Levy, Gallia G.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2022)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2022)
Get full text
Journal Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies
Skinner, Mark W., Négrier, Claude, Paz‐Priel, Ido, Chebon, Sammy, Jiménez‐Yuste, Victor, Callaghan, Michael U., Lehle, Michaela, Niggli, Markus, Mahlangu, Johnny, Shapiro, Amy, Shima, Midori, Campinha‐Bacote, Avrita, Levy, Gallia G., Oldenburg, Johannes, Mackensen, Sylvia, Pipe, Steven W.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2021)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2021)
Get full text
Journal Article
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS)
Mahlangu, Johnny, Oldenburg, Johannes, Callaghan, Michael U., Shima, Midori, Mancuso, Maria Elisa, Trask, Peter, Recht, Michael, Garcia, Claudia, Yang, Renchi, Lehle, Michaela, Macharia, Harrison, Asikanius, Elina, Levy, Gallia G., Kruse‐Jarres, Rebecca, von Mackensen, Sylvia
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2019)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2019)
Get full text
Journal Article
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study
Oldenburg, Johannes, Shima, Midori, Kruse‐Jarres, Rebecca, Santagostino, Elena, Mahlangu, Johnny, Lehle, Michaela, Selak Bienz, Nives, Chebon, Sammy, Asikanius, Elina, Trask, Peter, Mancuso, Maria Elisa, Jiménez‐Yuste, Victor, Mackensen, Sylvia, Levy, Gallia G.
Published in Pediatric blood & cancer (01.10.2020)
Published in Pediatric blood & cancer (01.10.2020)
Get full text
Journal Article
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi‐centre, non‐interventional study
Mahlangu, Johnny, Oldenburg, Johannes, Callaghan, Michael U., Shima, Midori, Santagostino, Elena, Moore, Maggie, Recht, Michael, Garcia, Claudia, Yang, Renchi, Lehle, Michaela, Macharia, Harrison, Asikanius, Elina, Levy, Gallia G., Kruse‐Jarres, Rebecca
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2018)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2018)
Get full text
Journal Article
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers
Lu, Genmin, Conley, Pamela B., Leeds, Janet M., Karbarz, Mark J., Levy, Gallia G., Mathur, Vandana S., Castillo, Janice, Crowther, Mark, Curnutte, John T.
Published in Blood advances (25.02.2020)
Published in Blood advances (25.02.2020)
Get full text
Journal Article
Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene
Lemmerhirt, Heidi L., Shavit, Jordan A., Levy, Gallia G., Cole, Suzanne M., Long, Jeffrey C., Ginsburg, David
Published in Blood (01.11.2006)
Published in Blood (01.11.2006)
Get full text
Journal Article